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Abstract
Introduction: The prevalence of use of any advance directives was 26% in 112
patients hospitalized in a cardiac care unit (CCU)/intensive care unit (ICU) in an
academic medical center.
Material and methods: We investigated in 2 community hospitals the prevalence
of use of advance directives (AD), health care proxy (HCP), legal guardian (LG),
and living will (LW) in 512 patients hospitalized in a CCU/ ICU approached for
AD and HCP .
Results: The use of AD was 22%, of HCP was 19%, of LG was 16%, and of LW
was 5%. 
Conclusions: The use of AD was 22%, of HCP was 19%, of LG was 16%, and of
LW was 5% in patients hospitalized in a CCU/ICU. Educational programs on use
of AD and of HCP need to be part of cardiovascular training programs and of
cardiovascular continuing medical education.
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Introduction
Cardiovascular disease is the number one cause of death in the United
States [1-9]. American College of Cardiology/American Heart Association
guidelines recommend the discussion of advance directives with patients
who have congestive heart failure [10]. The federal Patient Self-
Determination Act passed on November 5, 1990 mandates discussion of
advance directives with all hospitalized adults [11]. One study found the
prevalence of use of any advance directives in 112 patients hospitalized
in a cardiac care unit in an academic medical center was 26% [12]. The
present study reports the prevalence of use of advance directives, health
care proxy, legal guardian, and living will in 512 patients hospitalized in 
a cardiac care unit/intensive care unit in 2 community hospitals.
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Material and methods
We performed a chart review investigating the
prevalence of use of advance directives, health care
proxy, legal guardian, and living will in 312 patients
hospitalized in the cardiac care unit/intensive care
unit at Sound Shore Medical Center in New
Rochelle, New York and in 200 patients hospitalized
in the cardiac care unit/intensive care unit at Prince
George’s Hospital Center in Cheverly, Maryland who
were approached for the use of advance directives
and health care proxy. The 512 patients included
290 men and 222 women, mean age 61 ±19 years.
Of the 512 patients, 242 (47%) were whites, and
270 (53%) were nonwhites. Of the 512 patients, 279
(55%) were younger than 65 years, 141 (28%) were
aged 65-79 years, and 92 (18%) were aged ≥ 80
years. This study has been approved by our
Institutional Review Boards.
Results
Table I shows the prevalence of use of advance
directives, health care proxy, legal guardian, and
living will in the 512 patients hospitalized in 
a cardiac care unit/intensive care unit. Table II
shows the prevalence of use of advance directives,
health care proxy, legal guardian, and living will in
290 men and 222 women hospitalized in a cardiac
care unit/intensive care unit. No significant
differences were found.
Table III shows the prevalence of use of advance
directives, health care proxy, legal guardian, and
living will in 242 whites and 270 nonwhites
hospitalized in a cardiac care unit/intensive care
unit. Table III also lists levels of statistical
significance. Table IV shows the prevalence of use
of advance directives, health care proxy, legal
guardian, and living will in 279 patients younger
than 65 years, in 141 patients aged 65-79 years, and
in 92 pa  tients aged ≥ 80 years hospitalized in a car  -
diac care unit/intensive care unit. Table IV also lists
levels of statistical significance. 
Variable  Number (%)
Advance directives 114 (22%)
Health care proxy 97 (19%)
Legal guardian 80 (16%)
Living will  23 (5%)
Table I. Prevalence of use of advance directives,
health care proxy, legal guardian, and living will in
512 patients hospitalized in a cardiac care
unit/intensive care unit
Variable Men Women Value of p
(n = 290) (n = 222)
Advance directives 60 (21%) 54 (24%) Not significant
Health care proxy 53 (18%) 44 (20%) Not significant
Legal guardian 48 (17%) 32 (14%) Not significant
Living will 12 (4%) 11 (5%) Not significant
Table II. Prevalence of use of advance directives, health care proxy, legal guardian, and living will in men versus
women hospitalized in a cardiac care unit/intensive care unit
Variable Whites Nonwhites Value of p
(n = 242) (n = 270)
Advance directives 70 (29%) 44 (16%) < 0.001
Health care proxy 36 (15%) 61 (23%) < 0.05
Legal guardian 29 (12%) 51 (19%) < 0.05
Living will 19 (8%) 4 (2%) < 0.001
Table III. Prevalence of use of advance directives, health care proxy, legal guardian, and living will in whites versus
nonwhites  hospitalized in a cardiac care unit/intensive care unit
Variable < 65 Years 65-79 Years ≥ 80 Years
(n = 279) (n = 141) (n = 92)
Advance directives 50 (18%) 35 (25%) 29 (32%)
Health care proxy 53 (19%) 28 (20%) 16 (17%)
Legal guardian 42 (15%) 20 (14%) 18 (20%)
Living will 6 (2%) 12 (9%) 5 (5%)
Table IV. Prevalence of use of advance directives, health care proxy, legal guardian, and living will in patients aged
< 65 years, 65-79 years, and  ≥ 80 years hospitalized in a cardiac care unit/intensive care unit
For advance directives, p < 0.01 comparing  ≥ 80 years with < 65 years. For living will, p < 0.005 comparing 65-79 years with < 65 years
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Discussion
Cardiovascular disease is the number one cause
of death in the United States [1-9]. Advance
directives would seem to be an important part of
cardiovascular disease management. Heart failure
has a worse prognosis than many cancers [13]. Half
of heart failure patients die from sudden cardiac
death and half from pump failure [14]. Advance
directives may be more important for care of heart
failure patients than for cancer patients in whom
a terminal phase is identified [14]. Advance
directives should be a part of management of
patients with heart failure [10, 15] and other
cardiovascular disorders. Barriers to creating and
documenting advance directives include reluctance
of physicians and discomfort of physicians in
discussing advance directives with patients and
their families [16]. 
Of 112 patients, mean age 58 years, hospitalized
in a cardiac care unit in an academic medical; center,
29 patients (26%) had any advance directives [12].
Seven of the 112 patients (6%) had a living will as
their advance directives. This low prevalence of use
of advance directives occurred despite the federal
Patient Self-Determination Act of 1990 mandating
that all hospitalized adults be given the opportunity
to have advance directives [11]. 
The present study of 512 patients hospitalized
in a cardiac care unit/intensive care unit in 2 com  -
munity hospitals showed that the prevalence 
of use of advance directives was 22%, of a health
care proxy was 19%, of a legal guardian was 16%,
and of a living will was 5%. The prevalence of use
of advance directives, of a health care proxy, of 
a legal guardian, and of a living will was not
significantly different between hospitalized men
and women. Whites were significantly more likely
to have advance directives and a living will than
nonwhites. Nonwhites were significantly more likely
to have a health care proxy and a legal guardian
than whites. Patients aged ≥ 80 years were
significantly more likely to have advance directives
than patients younger than 65 years. Patients aged
65-79 years were significantly more likely to have
a living will than patients younger than 65 years.
The results from the present study and a smaller
previously published study [12] showed a low
prevalence of use of advance directives. To the best
of our knowledge, there are no other published
studies showing the prevalence of use of advance
directives in a cardiac care unit/intensive care unit.
Cardiovascular training programs and cardiovascular
continuing medical education programs need to
include discussions on advance directives, especially
with the population of elderly cardiovascular disease
patients growing. Physicians should be educated
to try to obtain advance directives in all patients
hospitalized in a cardiac care unit/intensive care
unit. A copy of advance directives if available should
be sent with the patient whenever transferred to 
a hospital or emergency department. An association
between advance directives and quality of end-of-
life care has been reported [17].
None of the authors have any conflicts of
interest.
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